Latest Industry study on Contract Research Organizations , Industry Global Contract Research Organizations

Global Contract Research Organizations (CROS) Market Analysis by Service (Pre-Clinical Services,
Phase-I, Ii, Iii, Iv and Other Laboratory Services); by Therapeutic Area (Nervous System, Oncology,
Cardiology, Respiratory, Infectious Diseases and Others); by Region (North America, Europe, Asia-
Pacific, Latin America, and Middle East & Africa (MEA) to 2025.
The global CROs market is segmented based on the type of service, therapeutic area and geographic
regions. Based on type of service, the market is segmented into pre-clinical services, phase-I, II, III, IV
and other laboratory services. Based on therapeutic area, the market is segmented into central nervous
system, oncology, cardiology, respiratory, infectious diseases and others. The market based on region, is
segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa (MEA).
Get Free 10 % Customization in this Report @ https://globalmarketforecasts.com/request-for-
sample/24
A Contract Research Organization (CROs) supports pharmaceutical, biotechnology and medical device
companies by offering end-to-end research services on a contract basis. These services include pre-
clinical & clinical research, clinical data management (CDM), biostatistics, pharmacovigilance, product
development, post-marketing surveillance, drug discovery solutions, site monitoring, and central
laboratory solutions, among others.
In the recent years, the global pharmaceutical sector has been witnessing an impressive growth owing
to advances in medical industry, particularly in emerging markets. This growth is expected to increase
product pipeline and FDA approvals in the coming years. In addition, growth in R&D activity is expected
increase the outsource of research activities. Furthermore, lack of specialized professionals for
toxicology testing is expected to increase the outsource activities in the coming years.
Top 10 Players Genomics Market Overview:
Pra Health Sciences, Inc.,
Pharmaceutical Product Development, LLC.,
PAREXEL International Corp.,
Quintiles Transnational Holdings Inc.